Atopic Dermatitis
Atopic dermatitis, commonly known as eczema, is a chronic skin condition that causes dry, itchy, and inflamed skin. It often appears in childhood but can persist into adulthood.
We are investigating the long-term safety and effectiveness of rocatinlimab for adults and adolescents with moderate-to-severe atopic dermatitis. The study compares the treatment's effects to a placebo in those who have previously responded to the medication.
Health conditions and diseases that the clinical trial is designed to study and treat.
Atopic dermatitis, commonly known as eczema, is a chronic skin condition that causes dry, itchy, and inflamed skin. It often appears in childhood but can persist into adulthood.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.